Celzar Injection (Gemcitabine): Advanced Nucleoside Analog for Solid Tumors – Global Supply by Ernest Oncology In the intensive field of 2026 oncology, Celzar Injection (containing the active ingredient Gemcitabine) remains a cornerstone therapeutic for several challenging malignancies. As a nucleoside metabolic inhibitor, Celzar is globally recognized for its efficacy in disrupting cancer cell replication, particularly in pancreatic, lung, and breast cancers. Its predictable safety profile and versatility in combination therapies make it a staple in both curative and palliative chemotherapy regimens. Ernest Oncology, the specialized oncology division of Ernest Pharmaceutical Pvt. Ltd., is a premier Exporter, Bulk Supplier, and Distributor from India. We facilitate the secure, GMP-compliant international distribution of Celzar Injection to the UK (London), USA, Abu Dhabi (UAE), Australia, and South Africa via validated pharmaceutical logistics. What is Celzar Injection? Celzar is a sterile solution or lyophilized powder for intravenous infusion, typically available in strengths of 200 mg and 1 g Vials. It is a pyrimidine antimetabolite that mimics the natural building blocks of DNA to halt tumor growth. Primary Therapeutic Indications Pancreatic Cancer: The gold-standard first-line treatment for patients with locally advanced or metastatic adenocarcinoma of the pancreas. Non-Small Cell Lung Cancer (NSCLC): Used in combination with Cisplatin for the first-line treatment of patients with inoperable, locally advanced, or metastatic NSCLC. Breast Cancer: Used in combination with Paclitaxel for the treatment of patients with metastatic breast cancer after failure of prior anthracycline-based chemotherapy. Ovarian Cancer: Utilized in combination with Carboplatin for patients with advanced ovarian cancer that has relapsed at least six months after completion of platinum-based therapy. Bladder Cancer: Frequently used in the gemcitabine-cisplatin (GC) regimen for advanced or metastatic transitional cell carcinoma. Technical Product Profile: Celzar (Gemcitabine) Feature Technical Specification Brand Name Celzar Active Ingredient Gemcitabine Hydrochloride Pharmacological Class Nucleoside Metabolic Inhibitor (Antimetabolite) Available Strengths “200 mg, 1 g Vials“ Manufacturer Leading GMP Indian Partners Dosage Form Injection / Lyophilized Powder for IV Infusion Storage 20°C to 25°C; Protect from light Mechanism of Action: DNA Synthesis Inhibition Celzar exerts its cytotoxic effect by “tricking“ the cancer cell during the DNA synthesis (S-phase) of the cell cycle: Metabolic Activation: Gemcitabine is metabolized intracellularly into active diphosphate (dFdCDP) and triphosphate (dFdCTP) nucleosides. Masked Chain Termination: The active triphosphate is incorporated into the DNA strand. After one additional nucleotide is added, the DNA polymerase is unable to proceed, effectively “locking“ the DNA and preventing repair. Dual Action: It also inhibits the enzyme ribonucleotide reductase, reducing the pool of natural deoxynucleotides available for DNA synthesis. Clinical Administration & Safety Infusion Duration: Typically administered as an IV infusion over 30 minutes. Hematologic Monitoring: The primary dose-limiting toxicity is myelosuppression. Regular CBC (Complete Blood Count) monitoring is mandatory. Tolerability: Celzar is generally well-tolerated, often used in elderly populations or patients with lower performance status where more aggressive taxanes might be contraindicated. Global Supply Chain: London, USA, UAE, Australia, & South Africa Ernest Oncology leverages India’s world-class pharmaceutical manufacturing to stabilize the global supply of Celzar. We ensure that B2B buyers receive products that meet the stringent 2026 quality benchmarks of international regulatory bodies. United Kingdom & London: Seamless supply to NHS Trusts and private oncology clinics in London via MHRA-compliant channels. United States: Reliable bulk procurement for specialized pharmacies, hospital systems, and oncology centers. Abu Dhabi & UAE: Priority shipping to the Middle East's premier cancer treatment hubs and medical cities. Australia & South Africa: Strategic distribution to regional wholesalers, ensuring availability for national chemotherapy programs. 📞 Contact Ernest Oncology — Pharmaceutical Exporter from India (Group of Ernest Pharmaceutical Pvt. Ltd.) Partner with a verified leader for the bulk procurement of high-quality oncology injectables. 🌐 Websites: www.oncologymedicinesupplier.com | www.ernestpharmaceuticals.com | www.ernestimpex.com | www.ernestvision.com 📧 Email: exports@ernestpharmaceuticals.com 📦 Business Type: Exporter | Bulk Supplier | Distributor 📲 WhatsApp: +91 93599 02383 🔗 Instant Chat: https://wa.me/919359902383
Washington, USA
08048034998
+919405476170
Chat with us
Chat with us
